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Although prescribing errors are one of the most common
causes of preventable iatrogenic injury, there have been
relatively few studies of their incidence and causes.  The
majority of the studies that have been carried out have been
based in secondary care.  This paper reviews what is currently
known about prescribing errors. It is suggested that
prescribing errors occur in at least 1-2% of all medication
orders written, cause harm in about 1% of admissions, and
have a wide range of causes.  Organisation-wide interventions
and cultural changes are likely to be required to prevent them.
However, useful first steps suggested include reporting
prescribing errors identified, formally reviewing pharmacists’
interventions and developing increased ‘error awareness’
amongst all health care professionals.
Introduction
Medical errors and the harm they can
cause are receiving increasing attention.
In the UK, the Department of Health
recently issued two reports highlighting
this problem1,2 and an entire issue of the
British Medical Journal has been
devoted to the subject3.  In the US, the
Institute of Medicine report ‘To err is
human: building a safer health system’4
has received worldwide publicity.  It is
clear that medical errors are causing
concern amongst patients, health care
professionals and governments alike.
Medication errors are one of the
most common types of medical error5.
It has been estimated that 1-2% of
patients admitted to US hospitals are
harmed as a result of medication
errors6, and that each error that results
in harm costs an additional US$5000
excluding legal costs7.  In the UK, it
has been recommended that serious
errors in the use of prescribed drugs
should be reduced by 40% by 20051.  In
a landmark US study, the majority of
the preventable adverse drug events
(mediation errors that result in harm)
were specifically attributed to
prescribing, rather than dispensing or
administration8,9.  It is therefore
surprising that there have been few
studies of prescribing errors and their
causes.  This paper reviews what we do
know about prescribing errors and
suggests some ways forward.  It is
based on a literature search carried out
using Medline and Embase databases to
identify studies of prescribing errors
published between 1980 and April
2001. Studies of standards of
prescription-writing, rather than
prescribing errors, are excluded.
Studying prescribing errors
A word of caution - the prescribing
error literature can be difficult to
interpret!  The results of many studies
do not distinguish between the
different types of medication error such
as prescribing, dispensing and
administration errors5,10-12.  Others do
not differentiate between medication
errors and adverse drug reactions13-15.
There are also wide differences in the
definitions and data collection methods
used6, although a standard practitioner-
led definition has now been
developed16.
How often do prescribing
errors occur?
Studies of the prescribing error
frequency generally fall into two
groups, those based on pharmacist
review of medication orders and those
based on the identification of patient
harm.  Each of these will be considered
in turn.  Most research into prescribing
errors has taken place in US hospitals,
although more recently studies have
also taken place elsewhere.
Pharmacists’ Review
of Medication Orders
In the US, pharmacists reviewing
medication orders in the course of their
prescription monitoring duties have
identified (and prevented) prescribing
errors in 0.3 to 1.9% of all medication
orders written17-20.  However, careful
examination of these studies reveals
some variation in the definitions of an
error used and comparisons amongst
them should be made with caution.
The most prolific authors in this
area are Lesar and colleagues, based in
a teaching hospital in New York State.
In their first study, an error was
identified in 0.3% of all medication
orders written17. The most common
category of error was ‘wrong dose’
errors.  When ‘problem orders’ (errors
without toxic potential, errors
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concerning doses that were unlikely to
be given, and missing information)
were excluded, the ‘significant’ error
rate was 0.2%.  As a result of these
findings, an ongoing prescribing error
monitoring programme was initiated.  A
total of nine years’ data were later
published21, which suggested that the
rate of significant errors had increased
from 0.2% to 0.4%.  However, as the
authors point out, these error rates are
likely to be an underestimate of the
true error rate, as many errors will go
undetected by dispensary-based
pharmacists.
In a further study, the same authors
examined a series of significant errors
to explore the most likely contributing
factors18. The contributory factors were
assigned by the investigators rather
than the prescribers involved.
Nevertheless, the results suggest that
the most common factors involved
knowledge about drugs and knowledge
about patient characteristics that affect
drug handling.  Analyses of data for
specific groups of drugs such
as antimicrobials have also been
published22.
There have been far fewer studies
outside of the US.  Twenty-five years
ago, Tesh and Beeley23 carried out a
retrospective review of 455 patients’
drug charts in a UK hospital.  These
investigators examined errors in drug
use and errors in prescription writing
such as prescribing by brand name.  It
was concluded that more than 30% of
all medication orders contained an error
of prescription writing.  The medical
notes were also reviewed for 385
patients to identify any contra-
indications to the drugs prescribed; it
was concluded that overall, 3.6% of all
medication orders were associated with
an error in drug use.
More recent UK studies have focused
on pharmacists’ clinical interventions.
For example, Hawkey et al.24 recorded
interventions in six hospitals.  It was
found that pharmacists made
interventions in about 2.9% of all
prescriptions, and that the majority
concerned drug doses.  In the former
North Thames Region of England,
hospital pharmacists record all
interventions made during one week
each year.  These data are then collated
and analysed centrally.  For example,
Barber et al.25 reported that 3501
interventions were made for 10,478
occupied beds during a one-week
period, equivalent to 33 interventions
per 100 beds per week.  However, such
studies do not allow firm conclusions to
be drawn regarding the frequency of
prescribing errors, as pharmacists’
interventions also include advice-
giving, formulary issues and patient
counselling.
In a more recent UK study,
pharmacists recorded details of all
prescribing errors identified in non-
obstetric inpatients during a four-week
period26.  The number of medication
orders written was estimated from a 1
in 5 sample of inpatients.  An error was
identified in 1.5% of all prescriptions
written, of which one quarter were
judged to be potentially serious.  As in
other studies, the majority (59%) were
associated with choice of dose.
In studies of this type, the errors
reported are those that pharmacists
identify and draw to the prescribers’
attention.  The medication orders
concerned are usually corrected before
the patient receives the medication.
There are therefore no adverse patient
outcomes.  In contrast, studies based
on the identification of harm include
only the subset of errors that reach the
patient and result in injury.
Identification of harm
Such studies usually include
iatrogenic injury of many different
kinds, but depending on how the data
are presented, the frequency of
medication-related events can usually
be identified.  The US Harvard study5 is
probably the most well known study of
iatrogenic harm and was based on the
retrospective review of more than
30,000 medical records.  This study
suggested that a medication error
caused harm in 0.7% of inpatients.  A
similar study in Australia identified a
figure of 1.8%27.  However, these
figures include both prescribing and
administration errors and the results do
not allow differentiation between them.
The Adverse Drug Event (ADE)
Prevention Study Group examined
medication-related harm in more
detail8.  This six-month study included
all adults admitted to a stratified
sample of wards in two large hospitals.
A medication error that resulted in
harm (‘preventable ADE’, in the authors’
terminology) was identified in 1.8% of
admissions.  Prescribing accounted for
the majority of these, representing
1.0% of all admissions.  The staff
involved were also interviewed to
obtain details of the circumstances
surrounding each error9.  As in Lesar et
al’s study18, the most common causes
were lack of knowledge about the drug
and lack of knowledge about the
patient.  More recently, a similar study
was carried out in two paediatric
hospitals; a preventable ADE was
identified in 0.4% of admissions28.
Why do prescribing errors
occur?
 Surprisingly, there has been little
research into the reasons why
prescribing errors occur.  While many
health care professionals have their
own hypotheses about the causes of
prescribing errors, there is little
evidence on which to base these
theories.  There is, however, a growing
body of research concerning human
error in other fields.
Theories of human error have been
used for some time to analyse errors in
high-risk environments such as aviation
and nuclear power, and have more
recently been applied to medicine29,30.
There are many different approaches to
the study of human error31, but
Reason’s accident causation model32 is
the most widely used.  This model is
based on the assumption that ‘active
failures’ on the part of front-line
individuals are largely the result of the
conditions in which they work, often
termed ‘error producing conditions’.
These in turn are the result of fallible
decisions at an organisational level,
known as ‘latent conditions’.  There is
therefore less focus on the individual
who makes the error and more on pre-
existing organisational factors. The
advantage of using this approach is
that it aids the identification of
relevant latent conditions, the primary
focus of intervention33.  Reason’s model
has now been used to investigate and
analyse incidents in obstetrics34, mental
health35 and other clinical settings29.  It
has also been used to develop a
protocol for the routine investigation of
adverse incidents in hospitals36.
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However, this approach has only
recently been applied to prescribing
errors37.  In this UK study, forty-four
interviews were conducted with
prescribers making potentially serious
errors.  It was found that active failures
were usually slips in attention or
mistakes such as not applying relevant
rules.  Doctors identified many error-
producing conditions; these included
work environment, workload, whether
or not they were prescribing for their
own patient, communication within
their team, physical and mental well-
being, and lack of knowledge.  Latent
conditions included lack of training,
low perceived importance of
prescribing, a hierarchical medical
team, and a lack of self-awareness of
errors.  It was concluded that amongst
other things, we need to create a
culture in which prescription writing is
seen as important and to sensitise
health care professionals to situations
in which errors are most likely to occur.
Conclusions
The literature suggests that
prescribing errors are a major source of
iatrogenic injury in hospitals.  While
little is known about the incidence of
errors in primary care, there is no
reason to suppose that prescribing
errors are any less frequent.  Careful
study of the literature also reveals that
there is wide variation in the
definitions of a prescribing error used,
and that little is known about their
causes or how they can be prevented.
Human error theory has been helpful in
the investigation of adverse incidents
in medicine, and has more recently
been applied to prescribing errors.
Large-scale studies of interventions to
reduce prescribing errors are now
required. However, useful first steps
suggested include reporting prescribing
errors identified, formally reviewing
pharmacists’ interventions and
developing increased ‘error awareness’
amongst all health care professionals.
Any successful intervention to reduce
prescribing errors is likely to require the
involvement of all health care
professionals. ✱
